Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BCTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Cable Car Capital, LP | 217K | $908K | β | 11.510% | 0.31% |
| 2 | SABBY MANAGEMENT, LLC | 74K | $310K | β | 3.924% | 5.42% |
| 3 | IRIDIAN ASSET MANAGEMENT LLC/CT | 65K | $272K | β | 3.451% | 0.11% |
| 4 | Marex Group plc | 30K | $176K | β | 1.593% | 0.00% |
| 5 | LuminArx Capital Management LP | 15K | $63K | β | 0.796% | 0.05% |
| 6 | UBS Group AG | 12K | $48K | +1708.9% | 0.613% | 0.00% |
| 7 | MORGAN STANLEY | 3K | $13K | -13.7% | 0.160% | 0.00% |
| 8 | NATIONAL BANK OF CANADA /FI/ | 802 | $3K | β | 0.043% | 0.00% |
| 9 | Federation des caisses Desjardins du Quebec | 455 | $2K | -62.2% | 0.024% | 0.00% |
| 10 | Allworth Financial LP | 100 | $419 | 0.0% | 0.005% | 0.00% |
| 11 | TD Waterhouse Canada Inc. | 19 | $78 | 0.0% | 0.001% | 0.00% |
| 12 | GROUP ONE TRADING, L.P. | 16 | $67 | -77.1% | 0.001% | 0.00% |
| 13 | Caitong International Asset Management Co., Ltd | 7 | $29 | β | 0.000% | 0.00% |
| 14 | HHM Wealth Advisors, LLC | 6 | $26 | 0.0% | 0.000% | 0.00% |
| 15 | WELLS FARGO & COMPANY/MN | 1 | $4 | 0.0% | 0.000% | 0.00% |
| 16 | ROYAL BANK OF CANADA | 100 | $0 | 0.0% | 0.005% | 0.00% |
| 17 | FNY Investment Advisers, LLC | 10 | $0 | 0.0% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in BCTX β a direct measure of their conviction.
Filings activity in BCTX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 17 | +31% | 34.40% | +33.07 pp | $2M | +2495% |
| Q4 2025 | 13 | +18% | 1.33% | 1.29 pp | $0M | 49% |
| Q3 2025 | 11 | 35% | 2.62% | 0.86 pp | $0M | 25% |
| Q2 2025 | 17 | +13% | 3.48% | +1.68 pp | $0M | +93% |
| Q1 2025 | 15 | 44% | 1.80% | 4.44 pp | $0M | 71% |
| Q4 2024 | 27 | +17% | 6.24% | 1.93 pp | $0M | 24% |
| Q3 2024 | 23 | +15% | 8.17% | 2.02 pp | $0M | 20% |
| Q2 2024 | 20 | β | 10.19% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BCTX stock.
Based on Q1 2026 13F filings, institutional ownership of BriaCell Therapeutics Corp. stands at 34.4%, held across 17 reporting institutions.
Cable Car Capital, LP is the largest reported institutional holder of BCTX, with approximately 216,821 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of BCTX.
Our composite Smart Money Score for BCTX is 53 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
7 institutions opened new positions in BCTX during Q1 2026, while 3 fully exited. 1 added to existing positions and 7 trimmed.
BCTX institutional ownership rose by 33.07 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 100.0% of all reported 13F value in BCTX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
BriaCell Therapeutics Corp. (BCTX) Institutional Ownership